Senior Director, SOX Compliance jobs in United States
cer-icon
Apply on Employer Site
company-logo

Madrigal Pharmaceuticals · 3 weeks ago

Senior Director, SOX Compliance

Madrigal Pharmaceuticals is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH). They are seeking a Senior Director, SOX Compliance to lead the company’s enterprise-wide Sarbanes-Oxley (SOX) program, ensuring compliance and enhancing internal controls while collaborating across various functions.

BiopharmaBiotechnologyMedical DevicePharmaceutical

Responsibilities

Maintain and enhance Madrigal’s SOX compliance program, including scoping, risk assessment, control design, documentation, testing, remediation, and ongoing monitoring
Partner with Finance, IT, Legal, HR, and business operations to ensure controls are properly designed and operating effectively across all key processes and systems
Lead the annual SOX risk assessment and control initiatives to ensure compliance efforts are efficient and aligned with business priorities
Lead annual internal and external process walkthroughs
Manage relationships with external auditors and consultants to ensure timely coordination of SOX testing and reporting
Drive continuous improvement of SOX-related processes, automation opportunities, and control environment maturity
Lead RFP and implementation process for SOX software
Serve as the primary point of contact for SOX matters across the organization, including executive management and the Audit Committee
Communicate control deficiencies, testing results, and remediation progress in a clear, actionable manner to senior leadership
Partner closely with Finance and IT leadership to ensure alignment between control requirements, system implementations, and process changes
Provide strategic insight and guidance on internal control implications of new business initiatives, system implementations, and policy changes
Monitor evolving regulatory expectations, PCAOB standards, and best practices in internal control frameworks (e.g., COSO 2013) to ensure Madrigal remains compliant and forward-looking
Evaluate emerging risks and operational changes that could impact the control environment, proposing proactive mitigations where appropriate
Promote a strong control culture throughout the organization by training and mentoring control owners and stakeholders

Qualification

SOX complianceInternal controlsRisk managementPCAOB standardsCOSO frameworksIT general controlsLeadership skillsStakeholder alignmentCommunication skillsMentoringCollaboration

Required

Bachelor's degree in Accounting, Finance, or related field; CPA or CIA required
15+ years of progressive experience Finance with 5+ years in SOX compliance, internal controls, and risk management — ideally including both public accounting and corporate experience in the biotech or pharmaceutical industry
Proven success building or transforming a SOX function within a complex, global organization
Deep knowledge of SOX 404 compliance, COSO frameworks, internal controls, and PCAOB standards
Strong understanding of IT general controls (ITGCs), automated controls, and system implementation risk
Exceptional communication and leadership skills with the ability to influence and align stakeholders across all levels of the organization
Demonstrated ability to build and mentor a high-performing team and effectively manage external partners
Willingness to travel up to ~10% (domestic and international)

Benefits

Flexible paid time off
Medical
Dental
Vision and life/disability insurance
401(k) offerings (i.e., traditional, Roth, and employer match)
Supplemental life insurance
Legal services
Mental health benefits through our Employee Assistance Program for employees and their family

Company

Madrigal Pharmaceuticals

twittertwittertwitter
company-logo
Madrigal Pharmaceuticals is a biopharmaceutical company developing therapeutics for the treatment of cardiovascular-metabolic diseases.

Funding

Current Stage
Public Company
Total Funding
$1.94B
Key Investors
Blue OwlHercules Capital
2025-07-22Post Ipo Debt· $350M
2024-03-18Post Ipo Equity· $690M
2023-09-28Post Ipo Equity· $500M

Leadership Team

leader-logo
Mardi C. Dier
Chief Financial Officer
linkedin
leader-logo
Carole Huntsman
Chief Commercial Officer (CCO)
linkedin
Company data provided by crunchbase